---
title: "CLOUDR (9955) issued a profit warning, expecting losses to widen to RMB 880 million to 980 million for the fiscal year 2025"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276431220.md"
description: "CLOUDR issued a profit warning, expecting the net loss for the fiscal year 2025 to expand to RMB 880 million to 980 million, a significant increase compared to RMB 491 million in 2024. The board pointed out that the increase in losses is mainly due to the group's strategic transformation and business restructuring, the sale of subsidiaries confirming large impairment losses, and a one-time provision for projects involving significant litigation. Despite the widening losses, the transformation has led to improved cash flow, with a projected net cash inflow from operating activities of RMB 50 million to 80 million for the fiscal year 2025"
datetime: "2026-02-20T10:09:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276431220.md)
  - [en](https://longbridge.com/en/news/276431220.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276431220.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/276431220.md) | [繁體中文](https://longbridge.com/zh-HK/news/276431220.md)


# CLOUDR (9955) issued a profit warning, expecting losses to widen to RMB 880 million to 980 million for the fiscal year 2025

CLOUDR (9955.HK) issued a profit warning, expecting to record a consolidated net loss of approximately RMB 880 million to RMB 980 million for the year ending December 2025, significantly larger than the net loss of RMB 491 million recorded for the year 2024.

The board of directors pointed out that the anticipated increase in losses is mainly due to the group's ongoing strategic transformation and business restructuring, focusing on core artificial intelligence capabilities and emphasizing the development of a high-quality and sustainable cash flow growth model. During the transformation process, the group confirmed substantial impairment losses from the sale of several subsidiaries, while also recording one-time specific provisions related to business projects involved in significant litigation or under judicial investigation, both of which contributed to the expanded scale of losses.

Despite the widening losses, the group's strategic transformation has brought positive changes in cash flow. Due to the strategic divestment of lower-margin medical supplies sales business, the transformation focuses on higher operational efficiency driven by AI P2M business, with expected net cash inflows from operating activities for the year 2025 ranging from approximately RMB 50 million to RMB 80 million; whereas the net cash outflow from operating activities recorded by the group for the year 2024 was approximately RMB 148 million, marking a significant breakthrough in cash flow status from net outflow to net inflow

### 相关股票

- [CLOUDR (09955.HK)](https://longbridge.com/zh-CN/quote/09955.HK.md)

## 相关资讯与研究

- [The AI Revolution and The 90s Internet Boom](https://longbridge.com/zh-CN/news/281005956.md)
- [06:05 ETgateretail and JK Tech Partner to Advance AI-Powered Inflight Retail Intelligence](https://longbridge.com/zh-CN/news/280996267.md)
- [Beijing Health Fy Loss For Year Hk$102 Million](https://longbridge.com/zh-CN/news/281055865.md)
- [TCS Rewires Enterprise Tech With AI](https://longbridge.com/zh-CN/news/280993412.md)
- [In the AI era, rewards will only be given to those with the knowledge.](https://longbridge.com/zh-CN/news/280977317.md)